American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
55.53
-0.95 (-1.68%)
Aug 28, 2026, 4:00 PM EDT - Market closed
American Healthcare REIT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Rental Revenue | 161.71 | 165.62 | 186.87 | 190.4 | 205.34 | 141.37 |
Other Revenue | 2,343 | 2,093 | 1,877 | 1,674 | 1,414 | 1,123 |
| 2,505 | 2,258 | 2,064 | 1,865 | 1,619 | 1,264 | |
Revenue Growth (YoY | 16.94% | 9.42% | 10.66% | 15.20% | 28.08% | 6.70% |
Property Expenses | 2,022 | 1,845 | 1,707 | 1,560 | 1,345 | 1,082 |
Selling, General & Administrative | 68.13 | 58.74 | 47.56 | 47.51 | 43.42 | 43.2 |
Depreciation & Amortization | 243.69 | 187.56 | 179.19 | 182.6 | 167.96 | 133.19 |
Total Operating Expenses | 2,334 | 2,091 | 1,934 | 1,790 | 1,556 | 1,258 |
Operating Income | 171.12 | 166.9 | 129.92 | 75 | 62.87 | 5.62 |
Interest Expense | -77.62 | -85.78 | -127.73 | -163.19 | -105.96 | -80.94 |
Currency Exchange Gain (Loss) | -1.73 | 3.18 | -0.77 | 2.31 | -5.21 | -0.56 |
Other Non-Operating Income | 7.18 | 2.67 | 10.78 | 0.88 | 3.56 | 10.05 |
EBT Excluding Unusual Items | 98.94 | 86.97 | 12.2 | -85 | -44.73 | -65.83 |
Merger & Restructuring Charges | - | - | -5.54 | - | -0.94 | - |
Impairment of Goodwill | - | - | - | - | -23.28 | - |
Gain (Loss) on Sale of Investments | 14.58 | 14.58 | - | 0.73 | 19.57 | - |
Gain (Loss) on Sale of Assets | 5.72 | -2.97 | 5.21 | 32.47 | 5.48 | -0.1 |
Asset Writedown | -17.71 | -49.94 | -45.76 | -24.42 | -54.58 | -3.34 |
Other Unusual Items | -3 | - | - | - | 25.68 | 16.95 |
Pretax Income | 98.54 | 48.65 | -33.89 | -76.22 | -72.8 | -52.31 |
Income Tax Expense | -24.04 | -22.17 | 1.71 | 0.66 | 0.59 | 0.96 |
Earnings From Continuing Operations | 122.57 | 70.82 | -35.6 | -76.89 | -73.38 | -53.27 |
Minority Interest in Earnings | -1.55 | -1.01 | -2.21 | 5.42 | -7.92 | 5.48 |
Net Income | 121.02 | 69.81 | -37.81 | -71.47 | -81.3 | -47.79 |
Net Income to Common | 121.02 | 69.81 | -37.81 | -71.47 | -81.3 | -47.79 |
Net Income Growth | - | - | - | - | - | - |
Basic Shares Outstanding | 182 | 166 | 131 | 66 | 66 | 50 |
Diluted Shares Outstanding | 183 | 167 | 131 | 66 | 66 | 50 |
Shares Change | 20.66% | 27.72% | 97.79% | 0.36% | 31.40% | 11.34% |
EPS (Basic) | 0.67 | 0.42 | -0.29 | -1.08 | -1.24 | -0.95 |
EPS (Diluted) | 0.66 | 0.42 | -0.29 | -1.08 | -1.24 | -0.95 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share | 1.000 | 1.000 | 1.000 | 1.000 | 1.600 | 0.100 |
Dividend Growth | 0% | 0% | 0% | -37.50% | 1500.00% | -49.93% |
Operating Margin | 6.83% | 7.39% | 6.30% | 4.02% | 3.88% | 0.44% |
Profit Margin | 4.83% | 3.09% | -1.83% | -3.83% | -5.02% | -3.78% |
EBITDA | 447.41 | 387.24 | 345.09 | 315.88 | 266.81 | 159.43 |
EBITDA Margin | 17.86% | 17.15% | 16.72% | 16.94% | 16.48% | 12.61% |
D&A For Ebitda | 276.29 | 220.34 | 215.18 | 240.88 | 203.93 | 153.81 |
EBIT | 171.12 | 166.9 | 129.92 | 75 | 62.87 | 5.62 |
EBIT Margin | 6.83% | 7.39% | 6.30% | 4.02% | 3.88% | 0.44% |
Funds From Operations (FFO) | 358.99 | 293.33 | 165.11 | - | - | 69.68 |
FFO Per Share | 1.97 | 1.76 | 1.26 | - | - | - |
Adjusted Funds From Operations (AFFO) | - | 293.33 | 165.11 | - | - | 69.68 |
AFFO Per Share | - | 1.76 | 1.26 | - | - | - |
FFO Payout Ratio | 49.73% | 55.75% | 73.22% | - | - | 32.70% |
Revenue as Reported | 2,502 | 2,260 | 2,071 | 1,867 | 1,643 | 1,282 |